Research Highlights

UB Department of Neurology research scientists and physician-scientists have made important and internationally recognized contributions to medical science, including patents, discoveries and treatment advances.

2/9/12
The drug most prescribed to people with relapsing multiple sclerosis.
11/15/19

The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.

2/15/18

The National Multiple Sclerosis Society (NMSS) has funded two separate projects led by researchers in the departments of Neurology and Pharmacology and Toxicology.

5/19/14

Building on a successful pilot study, Thomas J. Guttuso Jr., MD, associate professor of neurology and obstetrics and gynecology, will test the effectiveness of the anticonvulsant drug gabapentin in treating hyperemesis gravidarum, a rare but disabling condition of early pregnancy.

12/5/13
Dementia and Alzheimer’s disease may be related to a vascular abnormality in the internal jugular veins, according to a revealing pilot study by an international research team, including University at Buffalo scientists.
6/10/13

UB researchers and their global collaborators are building a growing body of evidence that links changes in the brain’s thalamus region to MS.

5/22/13

Research at UB’s Hunter James Kelly Research Institute has provided proof of principle for how a genetic mutation leads to some neuropathies.

4/4/13

UB researchers found that aerobic exercise may help restore normal cognitive function in patients who have suffered a concussion.

3/27/13
Balloon angioplasty does not improve outcomes for patients with multiple sclerosis—and, in a few cases, worsened symptoms, according to a landmark UB clinical trial.